Axsome Therapeutics (AXSM) Asset Utilization Ratio (2022 - 2026)

Axsome Therapeutics (AXSM) has 5 years of Asset Utilization Ratio data on file, last reported at 1.01 in Q1 2026.

• For the quarter ending Q1 2026, Asset Utilization Ratio rose 87.33% year-over-year to 1.01; the trailing twelve-month figure through Mar 2026 stood at 1.01 (up 87.33% YoY), and the FY2025 full-year result was 1.01, up 52.18% from the prior year.
• Asset Utilization Ratio grew to 1.01 in Q1 2026, from 0.94 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 1.01 in Q1 2026 to a low of 0.1 in Q3 2022.
• A 5-year average of 0.51 and a median of 0.47 in 2024 frame the typical range for Asset Utilization Ratio.
• Across the five-year window, Asset Utilization Ratio surged 273.01% in 2023 and increased 4.0% in 2024, its largest moves.
• Tracing AXSM's Asset Utilization Ratio over 5 years: stood at 0.15 in 2022, then jumped by 204.91% to 0.46 in 2023, then increased by 4.0% to 0.47 in 2024, then surged by 98.51% to 0.94 in 2025, then grew by 7.42% to 1.01 in 2026.
• Business Quant data shows AXSM's Asset Utilization Ratio at 1.01 in Q1 2026, 0.94 in Q4 2025, and 0.68 in Q3 2025.